Results 191 to 200 of about 92,350 (272)
ABSTRACT Purpose To describe trends in dispensing of monoclonal antibody biologics (mAbs) for autoimmune conditions during and around pregnancy. Methods We conducted a population‐wide study of women of reproductive age (14–49 years) resident in Lombardy, Italy, between 2012 and 2024.
Elisabeth Aiton +8 more
wiley +1 more source
ABSTRACT Introduction Non‐infectious uveitis (NIU) is a chronic immune‐mediated ocular inflammatory disease that may cause irreversible visual impairment. The comparative efficacy and safety of systemic immunomodulatory therapies, including conventional agents and biologics, remain incompletely defined.
Kai‐Yang Chen +2 more
wiley +1 more source
Efficacy and safety of interleukin-6 receptor inhibitors in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review and meta-analysis. [PDF]
Ali A +13 more
europepmc +1 more source
ABSTRACT Cytokine release syndrome (CRS) is a major dose‐limiting toxicity of T cell‐engaging immunotherapies. Existing CRS models are drug‐class‐specific; here we show that a single locked cytokine network captures CRS severity across mechanistically distinct drug classes, changing only drug‐specific upstream activation parameters.
Hajar Besbassi
wiley +1 more source
Reactivation of Cutaneous Leishmaniasis in a Rheumatoid Arthritis Patient Undergoing Tocilizumab Treatment. [PDF]
de Souza RM +6 more
europepmc +1 more source
ABSTRACT The idea of leveraging historical control data in randomized clinical trials (RCTs) has gained a lot of attention, in particular for rare disease and pediatric indications where conducting traditional and fully powered RCTs can be challenging.
David Jesse +4 more
wiley +1 more source
Summary B‐cell maturation antigen‐directed chimeric antigen receptor (CAR) T cells have revolutionized the treatment of relapsed/refractory multiple myeloma. However, no randomized head‐to‐head comparison of idecabtagene vicleucel (ide‐cel) and ciltacabtagene autoleucel (cilta‐cel) is available, and real‐world data suggest differences in efficacy and ...
Irene Strassl +23 more
wiley +1 more source
The role of IL-6 in atherosclerosis: a narrative review. [PDF]
Yasuda S, Tada H, Ako J.
europepmc +1 more source

